CORD-19:22616110b79baaf4c9d23f130a9ee35c64d991f7 / 383442-383607 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/22616110b79baaf4c9d23f130a9ee35c64d991f7","sourcedb":"CORD-19","sourceid":"22616110b79baaf4c9d23f130a9ee35c64d991f7","text":"There was a correlation between ESBL (+) production and resistant to many antibiotics that are generally used for ampiric treatment (p \u003c 0,05, Pearson correlation r:","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T503","span":{"begin":0,"end":165},"obj":"Sentence"}],"attributes":[{"subj":"T503","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"T19948","span":{"begin":0,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T19948","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2119","span":{"begin":6,"end":9},"obj":"Disease"}],"attributes":[{"id":"A2119","pred":"mondo_id","subj":"T2119","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T2119","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#ec93ca","default":true},{"id":"CORD-19-Sentences","color":"#93e4ec"},{"id":"CORD-19-PD-MONDO","color":"#ecda93"}]}]}}